NCC Officers' Training Academy
GWALIOR (Est 1965)

Sitagliptin

What is sitagliptin?

Sitagliptin is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus (not for type 1 diabetes).

Sitagliptin side effects

Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).

Stop taking sitagliptin and call your doctor right away if you have symptoms of pancreatitis: severe pain in your upper stomach spreading to your back, with or without vomiting.

Sitagliptin may cause serious side effects. Call your doctor at once if you have:

  • a severe skin reaction— itching, blisters, breakdown of the outer layer of skin;

  • severe or ongoing pain in your joints;

  • severely low blood sugar–extreme weakness, confusion, tremors, sweating, fast heartbeats, trouble speaking, nausea, vomiting, rapid breathing, fainting, and seizure (convulsions); or

  • kidney or heart problems–swelling, urinating less, rapid weight gain, feeling tired or short of breath.

Common side effects of sitagliptin may include:

Before taking this medicine

You should not use sitagliptin if you are allergic to it.

Tell your doctor if you have or have ever had:

It is not known if sitagliptin will harm an unborn baby. Follow your doctor’s instructions about using sitagliptin if you are pregnant or you become pregnant. Controlling diabetes is very important during pregnancy.

Usual Adult Dose for Diabetes Type 2:

100 mg orally once a day

Comments:
-When used in combination with an insulin secretagogue (e.g. sulfonylurea) or insulin, a lower dose of the insulin secretagogue or insulin may be required to reduce the risk of hypoglycemia.

Use: As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.

tablet (Januvia, Zituvio)

  • 25mg
  • 50mg
  • 100mg

oral solution (Brynovin)

  • 25mg/mL (120-mL bottle)
 

Type 2 Diabetes Mellitus

Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM)

100 mg PO qDay

Dosage Modifications

Renal impairment

  • eGFR ≥45 to <90 mL/min/1.73 m2: No dosage adjustment necessary
  • eGFR 30 to <45 mL/min/1.73 m2: 50 mg PO qDay
  • eGFR <30 mL/min/1.73 m2: 25 mg PO qDay
  • End-stage renal disease requiring hemodialysis or peritoneal dialysis: 25 mg PO qDay regardless of timing of dialysis

Hepatic impairment

  • Mild to moderate impairment: Dose adjustment not necessary
  • Severe impairment: Not studied

Interaction

 

Health Tools

BMI Tracker

×

BMI Calculator

Menstrual Cycle Tracker

Menstrual Cycle Tracker

Related/Similar Drugs

Scroll to Top